An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-05-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy and safety of the study drug known
as human regular U-500 insulin (U-500R) administered by continuous subcutaneous insulin
infusion (CSII) versus multiple daily injections (MDI) in participants with type 2 diabetes
mellitus.